Cargando…
Association between spirometry controlled chest CT scores using computer-animated biofeedback and clinical markers of lung disease in children with cystic fibrosis
Background: Computed tomography (CT) of the lungs is the gold standard for assessing the extent of structural changes in the lungs. Spirometry-controlled chest CT (SCCCT) has improved the usefulness of CT by standardising inspiratory and expiratory lung volumes during imaging. This was a single-cent...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5475300/ https://www.ncbi.nlm.nih.gov/pubmed/28649308 http://dx.doi.org/10.1080/20018525.2017.1318027 |
_version_ | 1783244536296767488 |
---|---|
author | Kongstad, Thomas Green, Kent Buchvald, Frederik Skov, Marianne Pressler, Tania Nielsen, Kim Gjerum |
author_facet | Kongstad, Thomas Green, Kent Buchvald, Frederik Skov, Marianne Pressler, Tania Nielsen, Kim Gjerum |
author_sort | Kongstad, Thomas |
collection | PubMed |
description | Background: Computed tomography (CT) of the lungs is the gold standard for assessing the extent of structural changes in the lungs. Spirometry-controlled chest CT (SCCCT) has improved the usefulness of CT by standardising inspiratory and expiratory lung volumes during imaging. This was a single-centre cross-sectional study in children with cystic fibrosis (CF). Using SCCCT we wished to investigate the association between the quantity and extent of structural lung changes and pulmonary function outcomes, and prevalence of known CF lung pathogens. Methods: CT images were analysed by CF-CT scoring (expressed as % of maximum score) to quantify different aspects of structural lung changes including bronchiectasis, airway wall thickening, mucus plugging, opacities, cysts, bullae and gas trapping. Clinical markers consisted of outcomes from pulmonary function tests, microbiological cultures from sputum and serological samples reflecting anti-bacterial and anti-fungal antibodies. Results: Sixty-four children with CF, median age (range) of 12.7 (6.4–18.1) years, participated in the study. The median (range) CF-CT total score in all children was 9.3% (0.4–46.8) with gas trapping of 40.7% (3.7–100) as the most abundant finding. Significantly higher median CF-CT total scores (21.9%) were found in patients with chronic infections (N = 12) including Gram-negative infection and allergic bronchopulmonary aspergillosis (ABPA) exhibiting CF-CT total scores of 14.2% (ns) and 24.0% (p < 0.01), respectively, compared to 8.0% in patients with no chronic lung infection. Lung clearance index (LCI) derived from multiple breath washout exhibited closest association with total CF-CT scores, compared to other pulmonary function outcomes. Conclusions: The most prominent structural lung change was gas trapping, while CF-CT total scores were generally low, both showing close association with LCI. Chronic lung infections, specifically in the form of ABPA, were associated with increased scores in lung changes. Further investigation of impact of infections with different microorganisms on extent and progression of structural CF lung disease is needed. |
format | Online Article Text |
id | pubmed-5475300 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-54753002017-06-23 Association between spirometry controlled chest CT scores using computer-animated biofeedback and clinical markers of lung disease in children with cystic fibrosis Kongstad, Thomas Green, Kent Buchvald, Frederik Skov, Marianne Pressler, Tania Nielsen, Kim Gjerum Eur Clin Respir J Article Background: Computed tomography (CT) of the lungs is the gold standard for assessing the extent of structural changes in the lungs. Spirometry-controlled chest CT (SCCCT) has improved the usefulness of CT by standardising inspiratory and expiratory lung volumes during imaging. This was a single-centre cross-sectional study in children with cystic fibrosis (CF). Using SCCCT we wished to investigate the association between the quantity and extent of structural lung changes and pulmonary function outcomes, and prevalence of known CF lung pathogens. Methods: CT images were analysed by CF-CT scoring (expressed as % of maximum score) to quantify different aspects of structural lung changes including bronchiectasis, airway wall thickening, mucus plugging, opacities, cysts, bullae and gas trapping. Clinical markers consisted of outcomes from pulmonary function tests, microbiological cultures from sputum and serological samples reflecting anti-bacterial and anti-fungal antibodies. Results: Sixty-four children with CF, median age (range) of 12.7 (6.4–18.1) years, participated in the study. The median (range) CF-CT total score in all children was 9.3% (0.4–46.8) with gas trapping of 40.7% (3.7–100) as the most abundant finding. Significantly higher median CF-CT total scores (21.9%) were found in patients with chronic infections (N = 12) including Gram-negative infection and allergic bronchopulmonary aspergillosis (ABPA) exhibiting CF-CT total scores of 14.2% (ns) and 24.0% (p < 0.01), respectively, compared to 8.0% in patients with no chronic lung infection. Lung clearance index (LCI) derived from multiple breath washout exhibited closest association with total CF-CT scores, compared to other pulmonary function outcomes. Conclusions: The most prominent structural lung change was gas trapping, while CF-CT total scores were generally low, both showing close association with LCI. Chronic lung infections, specifically in the form of ABPA, were associated with increased scores in lung changes. Further investigation of impact of infections with different microorganisms on extent and progression of structural CF lung disease is needed. Taylor & Francis 2017-05-02 /pmc/articles/PMC5475300/ /pubmed/28649308 http://dx.doi.org/10.1080/20018525.2017.1318027 Text en © 2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Article Kongstad, Thomas Green, Kent Buchvald, Frederik Skov, Marianne Pressler, Tania Nielsen, Kim Gjerum Association between spirometry controlled chest CT scores using computer-animated biofeedback and clinical markers of lung disease in children with cystic fibrosis |
title | Association between spirometry controlled chest CT scores using computer-animated biofeedback and clinical markers of lung disease in children with cystic fibrosis |
title_full | Association between spirometry controlled chest CT scores using computer-animated biofeedback and clinical markers of lung disease in children with cystic fibrosis |
title_fullStr | Association between spirometry controlled chest CT scores using computer-animated biofeedback and clinical markers of lung disease in children with cystic fibrosis |
title_full_unstemmed | Association between spirometry controlled chest CT scores using computer-animated biofeedback and clinical markers of lung disease in children with cystic fibrosis |
title_short | Association between spirometry controlled chest CT scores using computer-animated biofeedback and clinical markers of lung disease in children with cystic fibrosis |
title_sort | association between spirometry controlled chest ct scores using computer-animated biofeedback and clinical markers of lung disease in children with cystic fibrosis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5475300/ https://www.ncbi.nlm.nih.gov/pubmed/28649308 http://dx.doi.org/10.1080/20018525.2017.1318027 |
work_keys_str_mv | AT kongstadthomas associationbetweenspirometrycontrolledchestctscoresusingcomputeranimatedbiofeedbackandclinicalmarkersoflungdiseaseinchildrenwithcysticfibrosis AT greenkent associationbetweenspirometrycontrolledchestctscoresusingcomputeranimatedbiofeedbackandclinicalmarkersoflungdiseaseinchildrenwithcysticfibrosis AT buchvaldfrederik associationbetweenspirometrycontrolledchestctscoresusingcomputeranimatedbiofeedbackandclinicalmarkersoflungdiseaseinchildrenwithcysticfibrosis AT skovmarianne associationbetweenspirometrycontrolledchestctscoresusingcomputeranimatedbiofeedbackandclinicalmarkersoflungdiseaseinchildrenwithcysticfibrosis AT presslertania associationbetweenspirometrycontrolledchestctscoresusingcomputeranimatedbiofeedbackandclinicalmarkersoflungdiseaseinchildrenwithcysticfibrosis AT nielsenkimgjerum associationbetweenspirometrycontrolledchestctscoresusingcomputeranimatedbiofeedbackandclinicalmarkersoflungdiseaseinchildrenwithcysticfibrosis |